These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15151734)

  • 1. Risk of fetal exposure to folic acid antagonists.
    Wen SW; Walker M
    J Obstet Gynaecol Can; 2004 May; 26(5):475-80. PubMed ID: 15151734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of fetal exposure to tricyclic antidepressants.
    Wen SW; Walker M
    J Obstet Gynaecol Can; 2004 Oct; 26(10):887-92. PubMed ID: 15507199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes.
    Wen SW; Zhou J; Yang Q; Fraser W; Olatunbosun O; Walker M
    CMAJ; 2008 Dec; 179(12):1263-8. PubMed ID: 19047607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid antagonists during pregnancy and the risk of birth defects.
    Hernández-Díaz S; Werler MM; Walker AM; Mitchell AA
    N Engl J Med; 2000 Nov; 343(22):1608-14. PubMed ID: 11096168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.
    Matok I; Gorodischer R; Koren G; Landau D; Wiznitzer A; Levy A
    Br J Clin Pharmacol; 2009 Dec; 68(6):956-62. PubMed ID: 20002091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.
    Levy A; Matok I; Gorodischer R; Sherf M; Wiznitzer A; Uziel E; Koren G
    J Clin Pharmacol; 2012 Jan; 52(1):78-83. PubMed ID: 21343345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?
    Jungmann EM; Mercey D; DeRuiter A; Edwards S; Donoghue S; Booth T; Mohan D; Lyall H; Taylor GP
    Sex Transm Infect; 2001 Dec; 77(6):441-3. PubMed ID: 11714944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug use during pregnancy and breast-feeding. A classification system for drug information.
    Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
    Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The susceptibility of the fetus and child to chemical pollutants. Chemicals in human teratogenesis and transplacental carcinogenesis.
    Fraumeni JF
    Pediatrics; 1974 May; 53(5):807-12. PubMed ID: 4138009
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical look at the problem of drugs in pregnancy and their effect on the fetus.
    Yaffe SJ
    Can Med Assoc J; 1975 Mar; 112(6):728-33. PubMed ID: 1122445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
    Kulaga S; Zargarzadeh AH; Bérard A
    BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal folate deficiency and pregnancy wastage. IV. Effects of folic acid supplements, anticonvulsants, and oral contraceptives.
    Pritchard JA; Scott DE; Whalley PJ
    Am J Obstet Gynecol; 1971 Feb; 109(3):341-6. PubMed ID: 5549181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetal aminopterin syndrome].
    Harada M
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):88-9. PubMed ID: 11057154
    [No Abstract]   [Full Text] [Related]  

  • 15. Neural tube defects in relation to use of folic acid antagonists during pregnancy.
    Hernández-Díaz S; Werler MM; Walker AM; Mitchell AA
    Am J Epidemiol; 2001 May; 153(10):961-8. PubMed ID: 11384952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of drug substances on the embryo and fetus].
    Kudrin AN; Babkina TA; Pashin IuV
    Akush Ginekol (Mosk); 1978 Nov; (11):52-7. PubMed ID: 727394
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim during the 3 months before pregnancy: malformations in children.
    Prescrire Int; 2016 Jan; 25(167):17. PubMed ID: 26942256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndrome of multiple osseous deformities.
    Blessinger GM
    Lancet; 1970 Nov; 2(7680):982. PubMed ID: 4097624
    [No Abstract]   [Full Text] [Related]  

  • 19. ETIOLOGY OF ANTENATAL HYDROCEPHALUS INDUCED BY FOLIC ACID DEFICIENCY IN THE ALBINO RAT.
    STEMPAK JG
    Anat Rec; 1965 Mar; 151():287-95. PubMed ID: 14324085
    [No Abstract]   [Full Text] [Related]  

  • 20. A case-control study of maternal periconceptual and pregnancy recreational drug use and fetal malformation using hair analysis.
    David AL; Holloway A; Thomasson L; Syngelaki A; Nicolaides K; Patel RR; Sommerlad B; Wilson A; Martin W; Chitty LS
    PLoS One; 2014; 9(10):e111038. PubMed ID: 25360669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.